NL-OMON41795撤回不适用
Single centre protocol for donation of skin tissue and blood samples by patients suffering from psoriasis vulgaris for efficacy testing of a novel treatment in animal studies - Donation of skin and blood by psoriasis patients for mouse studies
TNO Triskelion0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •1. Written Informed Consent obtained
- •2. Suffering of mild to moderate psoriasis vulgaris, defined as a PASI score of 18 or less and a minimum of body surface index of 3% at Visit 1
排除标准
- •1. Suffering from extensive psoriasis or having had non plaque or drug-induced forms of psoriasis
- •2. Undergoing light therapy or any systemic therapy
- •3. Diagnosis of a recent serious infection
- •4. A medical history of chronic or recurrent infectious disease
研究者
相似试验
已完成
不适用
Single center protocol for donation of skin tissue and blood samples by patients suffering from psoriasis vulgaris for the validation of animal studies for the development of new treatments for psoriasis vulgarisDonatie weefsel voor proefdieronderzoek (gehumaniseerd muismodel) voor psoriasisPreclinical Psoriasis research in laboratory mouse studyNL-OMON42314TNO Triskelion25
已完成
不适用
Single center ethical protocol for donation of skin tissue and blood samples by patients suffering from psoriasis vulgaris for animal studies concerning development of new treatments for psoriasis vulgaris.Donatie weefsel voor proefdieronderzoek voor psoriasis (gehumaniseerd muismodel)Psoriasis research in laboratory animals10014982NL-OMON43016Triskelion25
已完成
不适用
Single center ethical protocol for donation of skin tissue and blood samples by patients suffering from psoriasis vulgaris for animal studies concerning development of new treatments for psoriasis vulgarisDonatie weefsel voor proefdieronderzoek (gehumaniseerd muismodel) voor psoriasisPsoriasis research in laboratory animal studyNL-OMON40921TNO Triskelion20
招募中
1 期
Infusion of donor-derived CMV peptide-specific CTL after allogeneic HSCTImmune reconstitution post-allogeneic haematopoietic stem cell transplantationOther - Other blood disordersACTRN12605000213640Department of Haematology, Westmead Hospital12
已完成
4 期
Management of split-thickness skin graft donor site: An open, prospective, randomized, controlled clinical trial for comparison of three different dressing materials.Split-skin grafting donor sitesDRKS00030018QRSKIN GmbH69